Dalbavancin for the treatment of acute bacterial skin and skin structure infections
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dalbavancin for the treatment of acute bacterial skin and skin structure infections
Authors
Keywords
-
Journal
EXPERT OPINION ON PHARMACOTHERAPY
Volume 16, Issue 13, Pages 2073-2081
Publisher
Informa Healthcare
Online
2016-02-13
DOI
10.1517/14656566.2015.1075508
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Extended-Duration Dosing and Distribution of Dalbavancin into Bone and Articular Tissue
- (2015) Michael W. Dunne et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A thorough QT study with dalbavancin: A novel lipoglycopeptide antibiotic for the treatment of acute bacterial skin and skin-structure infections
- (2015) Michael W. Dunne et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Demographic and Treatment Patterns for Infections in Ambulatory Settings in the United States, 2006-2010
- (2014) Larissa May et al. ACADEMIC EMERGENCY MEDICINE
- PBP2a Mutations Causing High-Level Ceftaroline Resistance in Clinical Methicillin-Resistant Staphylococcus aureus Isolates
- (2014) S. Wesley Long et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Incidence and cost of hospitalizations associated with Staphylococcus aureusskin and soft tissue infections in the United States from 2001 through 2009
- (2014) Jose A Suaya et al. BMC INFECTIOUS DISEASES
- Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
- (2014) Dennis L. Stevens et al. CLINICAL INFECTIOUS DISEASES
- Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial
- (2014) Gregory J Moran et al. LANCET INFECTIOUS DISEASES
- Single-Dose Oritavancin in the Treatment of Acute Bacterial Skin Infections
- (2014) G. Ralph Corey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Once-Weekly Dalbavancin versus Daily Conventional Therapy for Skin Infection
- (2014) Helen W. Boucher et al. NEW ENGLAND JOURNAL OF MEDICINE
- A National Survey of Skin Infections, Care Behaviors and MRSA Knowledge in the United States
- (2014) Jocelyn R. Wilder et al. PLoS One
- Incidence, microbiology, and patient characteristics of skin and soft-tissue infections in a U.S. population: a retrospective population-based study
- (2013) Gary Thomas Ray et al. BMC INFECTIOUS DISEASES
- Comprehensive update of dalbavancin activity when tested against uncommonly isolated streptococci, Corynebacterium spp., Listeria monocytogenes, and Micrococcus spp. (1357 strains)
- (2013) Ronald N. Jones et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Update of dalbavancin spectrum and potency in the USA: report from the SENTRY Antimicrobial Surveillance Program (2011)
- (2013) Ronald N. Jones et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Surveillance of dalbavancin potency and spectrum in the United States (2012)
- (2013) Ronald N. Jones et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Epidemics of Community-Associated Methicillin-Resistant Staphylococcus aureus in the United States: A Meta-Analysis
- (2013) Vanja M. Dukic et al. PLoS One
- New antibiotics for bad bugs: where are we?
- (2013) Matteo Bassetti et al. Annals of Clinical Microbiology and Antimicrobials
- A Carrier Protein Strategy Yields the Structure of Dalbavancin
- (2012) Nicoleta J. Economou et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Skin and Soft‐Tissue Infections Requiring Hospitalization at an Academic Medical Center: Opportunities for Antimicrobial Stewardship
- (2010) Timothy C. Jenkins et al. CLINICAL INFECTIOUS DISEASES
- A European survey of antibiotic management of methicillin-resistant Staphylococcus aureus infection: current clinical opinion and practice
- (2010) M. Dryden et al. CLINICAL MICROBIOLOGY AND INFECTION
- Resistance or decreased susceptibility to glycopeptides, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus
- (2010) Esteban Nannini et al. CURRENT OPINION IN PHARMACOLOGY
- Activities of Dalbavancin against a Worldwide Collection of 81,673 Gram-Positive Bacterial Isolates
- (2009) D. J. Biedenbach et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multicenter evaluation of the in vitro activity of dalbavancin tested against staphylococci and streptococci in 5 European countries: results from the DECIDE Surveillance Program (2007)
- (2009) Douglas J. Biedenbach et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Evaluation of dalbavancin, tigecycline, minocycline, tetracycline, teicoplanin and vancomycin against community-associated and multidrug-resistant hospital-associated meticillin-resistant Staphylococcus aureus
- (2009) Vanthida Huang et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Pharmacokinetics of Dalbavancin in Patients With Renal or Hepatic Impairment
- (2009) Thomas Marbury et al. JOURNAL OF CLINICAL PHARMACOLOGY
- National Trends in Ambulatory Visits and Antibiotic Prescribing for Skin and Soft-Tissue Infections
- (2008) Adam L. Hersh ARCHIVES OF INTERNAL MEDICINE
- Pharmacokinetic-Pharmacodynamic Modeling of Dalbavancin, a Novel Glycopeptide Antibiotic
- (2008) James A. Dowell et al. JOURNAL OF CLINICAL PHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started